E, M., B, M., B, L., F, C., G, G., A, S., . . . L, S. (2024). Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors. Frontiers in immunology, 15, 1336566. https://doi.org/10.3389/fimmu.2024.1336566
Chicago Style (17th ed.) CitationE, Muraro, et al. "Antibody Dependent Cellular Cytotoxicity-inducing Anti-EGFR Antibodies as Effective Therapeutic Option for Cutaneous Melanoma Resistant to BRAF Inhibitors." Frontiers in Immunology 15 (2024): 1336566. https://doi.org/10.3389/fimmu.2024.1336566.
MLA (9th ed.) CitationE, Muraro, et al. "Antibody Dependent Cellular Cytotoxicity-inducing Anti-EGFR Antibodies as Effective Therapeutic Option for Cutaneous Melanoma Resistant to BRAF Inhibitors." Frontiers in Immunology, vol. 15, 2024, p. 1336566, https://doi.org/10.3389/fimmu.2024.1336566.